The U.S. Senate voted to postpone a federal ban on floral hemp products until December, providing temporary relief to Montana processors who faced lost revenue and supply chain disruption under stricter regulations set to take effect in November.
The 2018 Farm Bill legalized hemp products containing no more than 0.3 percent THC by dry weight. Montana lawmakers authorized the state’s use of this federal framework to allow sales of hemp-derived goods. However, legislation signed last year would have reduced the legal THC threshold for containers after November 12, effectively banning many floral hemp products currently on the market.
The Senate delay pushes that deadline to December, buying the industry time to navigate regulatory uncertainty. Big Sky Scientific, a Sun River-based processor that extracts CBD from hemp into gummies, tinctures, and beverages, stands among the companies benefiting from the postponement. The products are marketed for sleep, anxiety, and inflammation relief.
Farrell, CEO of Big Sky Scientific, told KTVH that “this is a huge win for the nation. And this is a huge win for Montana.” He added that the restrictions have “been extremely hard on ourselves, our farmers, our customers, consumers.”
The Alliance for Youth Substance Abuse Prevention has raised concerns that doctored hemp products are reaching children, citing public health risks as justification for tighter federal controls.
U.S. Senator Tim Sheehy, a Montana Republican, and Senator Amy Klobuchar of Minnesota are leading a bipartisan effort to establish comprehensive industry regulation rather than outright prohibition. Their approach aims to balance commerce with consumer safety through uniform standards rather than a categorical ban.
The Senate measure still requires passage in the U.S. House before taking effect. The December deadline provides both lawmakers and the hemp industry a window to reach consensus on permanent regulatory language, though questions remain about whether Congress will act before year’s end or allow the restrictions to proceed as written.
The hemp processing sector in Montana has grown as farmers and businesses sought legal alternatives to traditional cannabis cultivation. The regulatory ambiguity has created both opportunity and risk—companies like Big Sky Scientific have invested in processing facilities and supply chains, only to face potential overnight market closure if federal rules tighten.
The outcome of the House vote and the shape of any final regulatory compromise will determine whether Montana’s hemp processors can sustain their current business models or must pivot to other product categories or markets.
